Harnessing the Power of Exosomes
From Exosomes to Insight
Rivela Diagnostics envisions a world in which a simple blood drop is sufficient to allow screening for all cancers at the earliest detectable moment, enabling enhanced, personalised patient treatments and outcomes. By achieving this goal, we will reduce the devastating impact of the rise of global cancer rates and improve the lives of those affected by the disease.
The only exosome focused company selling globally the largest variety of standards, reagents and products for EV research, and providing a large variety of services including EVs isolation, characterization, early R&D projects and pilot studies.